Infection Events Synthetic Swarm for Tracking Independent Immunodeficiency Virus SIVmac 239 Molecularly Tagged Simian
暂无分享,去创建一个
Jeffrey | Octavio A. Quiñones | W. | L. Picker | C. Fennessey | B. Keele | M. Piatak | Haesun Park | K. Oswald | G. Alvord | J. Estes | C. Kahl | L. Newman | G. Q. D. Prete | C. Reid | J. Smedley | L. Lipkey | G. D. Prete | D. Lifson
[1] C. Fennessey,et al. Using nonhuman primates to model HIV transmission , 2013, Current opinion in HIV and AIDS.
[2] G. Learn,et al. Heterogeneity in Neutralization Sensitivities of Viruses Comprising the Simian Immunodeficiency Virus SIVsmE660 Isolate and Vaccine Challenge Stock , 2013, Journal of Virology.
[3] Christopher J. Miller,et al. Comparative Characterization of Transfection- and Infection-Derived Simian Immunodeficiency Virus Challenge Stocks for In Vivo Nonhuman Primate Studies , 2013, Journal of Virology.
[4] G. Learn,et al. Molecular identification, cloning and characterization of transmitted/founder HIV-1 subtype A, D and A/D infectious molecular clones. , 2013, Virology.
[5] D. Montefiori,et al. Protection Afforded by an HIV Vaccine Candidate in Macaques Depends on the Dose of SIVmac251 at Challenge Exposure , 2013, Journal of Virology.
[6] D. Watkins,et al. A trivalent recombinant Ad5 gag/pol/nef vaccine fails to protect rhesus macaques from infection or control virus replication after a limiting-dose heterologous SIV challenge. , 2012, Vaccine.
[7] J. Shiver,et al. Low-Dose Penile SIVmac251 Exposure of Rhesus Macaques Infected with Adenovirus Type 5 (Ad5) and Then Immunized with a Replication-Defective Ad5-Based SIV gag/pol/nef Vaccine Recapitulates the Results of the Phase IIb Step Trial of a Similar HIV-1 Vaccine , 2011, Journal of Virology.
[8] J. Lifson,et al. SIVmac251 is inefficiently transmitted to rhesus macaques by penile inoculation with a single SIVenv variant found in ramp-up phase plasma. , 2011, AIDS research and human retroviruses.
[9] B. Keele,et al. Comparison of systemic and mucosal vaccination: impact on intravenous and rectal SIV challenge , 2011, Mucosal Immunology.
[10] Christopher J. Miller,et al. TRIM5α Does Not Affect Simian Immunodeficiency Virus SIVmac251 Replication in Vaccinated or Unvaccinated Indian Rhesus Macaques following Intrarectal Challenge Exposure , 2011, Journal of Virology.
[11] John P. Moore,et al. Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody , 2011, Proceedings of the National Academy of Sciences.
[12] Matthew S. Lewis,et al. Profound early control of highly pathogenic SIV by an effector-memory T cell vaccine , 2011, Nature.
[13] M. Essex,et al. Transmission of Single and Multiple Viral Variants in Primary HIV-1 Subtype C Infection , 2011, PloS one.
[14] Alan S. Perelson,et al. Transmission of Single HIV-1 Genomes and Dynamics of Early Immune Escape Revealed by Ultra-Deep Sequencing , 2010, PloS one.
[15] B. Haynes,et al. Low-Dose Mucosal Simian Immunodeficiency Virus Infection Restricts Early Replication Kinetics and Transmitted Virus Variants in Rhesus Monkeys , 2010, Journal of Virology.
[16] G. Shaw,et al. A Limited Number of Simian Immunodeficiency Virus (SIV) env Variants Are Transmitted to Rhesus Macaques Vaginally Inoculated with SIVmac251 , 2010, Journal of Virology.
[17] Alan S. Perelson,et al. High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men , 2010, PLoS pathogens.
[18] H. Chu,et al. Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants , 2009, Journal of Virology.
[19] A. Perelson,et al. Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection , 2009, The Journal of experimental medicine.
[20] Alan S. Perelson,et al. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1 , 2009, The Journal of experimental medicine.
[21] D. Watkins,et al. Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge , 2009, Journal of Virology.
[22] Cynthia A. Derdeyn,et al. Inflammatory Genital Infections Mitigate a Severe Genetic Bottleneck in Heterosexual Transmission of Subtype A and C HIV-1 , 2009, PLoS pathogens.
[23] Hui Li,et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.
[24] R. Gorelick,et al. HIV-1 inactivation by 4-vinylpyridine is enhanced by dissociating Zn(2+) from nucleocapsid protein. , 2008, Virology.
[25] B. Korber,et al. Deciphering Human Immunodeficiency Virus Type 1 Transmission and Early Envelope Diversification by Single-Genome Amplification and Sequencing , 2008, Journal of Virology.
[26] M. Carrington,et al. Mamu-B*08-Positive Macaques Control Simian Immunodeficiency Virus Replication , 2007, Journal of Virology.
[27] J. Lifson,et al. Highly sensitive SIV plasma viral load assay: practical considerations, realistic performance expectations, and application to reverse engineering of vaccines for AIDS , 2005, Journal of medical primatology.
[28] D. Robertson,et al. Molecular Epidemiology of Simian Immunodeficiency Virus SIVsm in U.S. Primate Centers Unravels the Origin of SIVmac and SIVstm , 2005, Journal of Virology.
[29] John W. Mellors,et al. Multiple, Linked Human Immunodeficiency Virus Type 1 Drug Resistance Mutations in Treatment-Experienced Patients Are Missed by Standard Genotype Analysis , 2005, Journal of Clinical Microbiology.
[30] R. Desrosiers,et al. Importance of the nef gene for maintenance of high virus loads and for development of AIDS , 1991, Cell.
[31] R. Desrosiers,et al. The complete nucleotide sequence of a pathogenic molecular clone of simian immunodeficiency virus. , 1990, AIDS research and human retroviruses.
[32] R. Desrosiers,et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. , 1985, Science.
[33] J. Lifson,et al. Simian immunodeficiency virus infection of monkeys as a model system for the study of AIDS pathogenesis, treatment, and prevention. , 2000, Advances in pharmacology.